{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:18:00Z","timestamp":1791919080977,"version":"4.3.4"},"reference-count":76,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2012,7,24]],"date-time":"2012-07-24T00:00:00Z","timestamp":1343088000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0041450","type":"journal-article","created":{"date-parts":[[2012,7,24]],"date-time":"2012-07-24T21:22:49Z","timestamp":1343164969000},"page":"e41450","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Temporal Separation of Aggregation and Ubiquitination during Early Inclusion Formation in Transgenic Mice Carrying the Huntington\u2019s Disease Mutation"],"prefix":"10.1371","volume":"7","author":[{"given":"Belvin","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Kielar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Jennifer","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,7,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes.","volume":"72","year":"1993","journal-title":"Cell"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.","volume":"90","author":"SW Davies","year":"1997","journal-title":"Cell"},{"key":"ref3","article-title":"Neuronal nuclear-cytoplasmic changes in Huntington\u2019s chorea: electron microscope investigations. In Chase TN, Wexler NS and Barbeau A, eds. <italic>Advances in Neurology, Huntington\u2019s Disease<\/italic>.","author":"L Roizin","year":"1979"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.","volume":"277","author":"M DiFiglia","year":"1997","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00401-007-0287-5","article-title":"CAG repeat disorder models and human neuropathology: similarities and differences.","volume":"115","author":"M Yamada","year":"2008","journal-title":"Acta Neuropathol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.brainresrev.2008.12.001","article-title":"The R6 lines of transgenic mice: a model for screening new therapies for Huntington\u2019s disease.","volume":"59","author":"JM Gil","year":"2009","journal-title":"Brain Res Rev"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0092-8674(00)80464-X","article-title":"Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse.","volume":"91","author":"JM Ordway","year":"1997","journal-title":"Cell"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/hmg\/7.5.783","article-title":"Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture.","volume":"7","author":"JK Cooper","year":"1998","journal-title":"Hum Mol Genet"},{"key":"ref9","first-page":"265","article-title":"Intracellular inclusions, pathological markers in diseases caused by expanded polyglutamine tracts?","volume":"36","author":"DC Rubinsztein","year":"1999","journal-title":"J Med Genet"},{"key":"ref10","first-page":"15","article-title":"Intracellular green fluorescent protein-polyalanine aggregates are associated with cell death.","volume":"15","author":"J Rankin","year":"2003","journal-title":"Biochem J"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature01301","article-title":"Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders.","volume":"421","author":"I S\u00e1nchez","year":"2003","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nm985","article-title":"Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease.","volume":"10","author":"M Tanaka","year":"2004","journal-title":"Nat Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"16685","DOI":"10.1073\/pnas.0707842104","article-title":"Chopra V, Fox JH, Lieberman G, Dorsey K, Matson W, et al. ()2007 A small-molecule therapeutic lead for Huntington\u2019s disease: preclinical pharmacology and efficacy of C2\u20138 in the R6\/2 transgenic mouse.","volume":"104","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.nbd.2008.01.014","article-title":"Tiagabine is neuroprotective in the N171\u201382Q and R6\/2 mouse models of Huntington\u2019s disease.","volume":"30","author":"N Masuda","year":"2008","journal-title":"Neurobiol Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","article-title":"Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.","volume":"95","author":"F Saudou","year":"1998","journal-title":"Cell"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","article-title":"Nuclear and neuropil aggregates in Huntington\u2019s disease: relationship to neuropathology.","volume":"19","author":"CA Gutekunst","year":"1999","journal-title":"J Neurosci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1531-8249(199912)46:6<842::AID-ANA6>3.0.CO;2-O","article-title":"Huntington aggregates may not predict neuronal death in Huntington\u2019s disease.","volume":"46","author":"S Kuemmerle","year":"1999","journal-title":"Ann Neurol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1046\/j.0953-816x.2001.01767.x","article-title":"Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene.","volume":"14","author":"O Hansson","year":"2001","journal-title":"Eur J Neurosci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death.","volume":"431","author":"M Arrasate","year":"2004","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"11402","DOI":"10.1073\/pnas.0503634102","article-title":"Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions.","volume":"102","author":"EJ Slow","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1073\/pnas.0511256103","article-title":"Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington\u2019s and Parkinson\u2019s diseases.","volume":"103","author":"RA Bodner","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.brainresbull.2007.08.005","article-title":"Time-lapse analysis of aggregate formation in an inducible PC12 cell model of Huntington\u2019s disease reveals time-dependent aggregate formation that transiently delays cell death.","volume":"75","author":"B Gong","year":"2008","journal-title":"Brain Res Bull"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/sj.cdd.4402261","article-title":"Mutant huntingtin can paradoxically protect neurons from death.","volume":"15","author":"T Zuchner","year":"2008","journal-title":"Cell Death Differ"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.nbd.2008.11.015","article-title":"Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6\/2 mice.","volume":"33","author":"AJ Morton","year":"2009","journal-title":"Neurobiol Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1023\/A:1010887421592","article-title":"Progressive formation of inclusions in the striatum and hippocampus of mice transgenic for the human Huntington\u2019s disease mutation.","volume":"29","author":"AJ Morton","year":"2000","journal-title":"J Neurocytol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1750-3639.2006.00040.x","article-title":"Neuronal intranuclear and neuropil inclusions for pathological assessment of Huntington\u2019s disease.","volume":"17","author":"M Maat-Schieman","year":"2007","journal-title":"Brain Pathol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/ng0298-150","article-title":"Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates.","volume":"18","author":"D Martindale","year":"1998","journal-title":"Nat Genet"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/NEN.0b013e318198d320","article-title":"Neuroanatomic profile of polyglutamine immunoreactivity in Huntington disease brains.","volume":"68","author":"ES Herndon","year":"2009","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1093\/hmg\/ddh188","article-title":"Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseases.","volume":"13","author":"R de Pril","year":"2004","journal-title":"Hum Mol Genet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00418-007-0272-z","article-title":"Differential morphology and composition of inclusions in the R6\/2 mouse and PC12 cell models of Huntington\u2019s disease.","volume":"127","author":"J Wanderer","year":"2007","journal-title":"Histochem Cell Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/NEN.0b013e31818e8951","article-title":"Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease.","volume":"67","author":"C Schwab","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.","volume":"87","author":"L Mangiarini","year":"1996","journal-title":"Cell"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington\u2019s disease mutation.","volume":"19","author":"RJ Carter","year":"1999","journal-title":"J Neurosci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","article-title":"discrimination learning impairments in mice expressing the human Huntington\u2019s disease mutation.","volume":"19","author":"LA Lione","year":"1999","journal-title":"J Neurosci"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1523\/JNEUROSCI.20-13-05115.2000","article-title":"Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington\u2019s disease mutation.","volume":"20","author":"KP Murphy","year":"2000","journal-title":"J Neurosci"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/j.1460-9568.2005.04349.x","article-title":"A similar impairment in CA3 mossy fibre LTP in the R6\/2 mouse model of Huntington\u2019s disease and in the complexin II knockout mouse.","volume":"22","author":"HE Gibson","year":"2005","journal-title":"Eur J Neurosci"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.1073\/pnas.120166397","article-title":"Severe deficiencies in dopamine signaling in presymptomatic Huntington\u2019s disease mice.","volume":"97","author":"JA Bibb","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0361-9230(01)00599-8","article-title":"New anti-huntingtin monoclonal antibodies: implications for huntingtin conformation and its binding proteins.","volume":"56","author":"J Ko","year":"2001","journal-title":"Brain Res Bull"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"8808","DOI":"10.1074\/jbc.M109.075028","article-title":"Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease.","volume":"285","author":"C Landles","year":"2010","journal-title":"J Biol Chem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"10541","DOI":"10.1523\/JNEUROSCI.0146-10.2010","article-title":"Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington\u2019s disease molecular pathogenesis.","volume":"30","author":"J Miller","year":"2010","journal-title":"J Neurosci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/jmbi.2001.4850","article-title":"Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity.","volume":"311","author":"S Chen","year":"2001","journal-title":"J Mol Biol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/cne.10295","article-title":"Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6\/2 transgenic mice.","volume":"449","author":"CA Meade","year":"2002","journal-title":"J Comp Neurol"},{"key":"ref43","first-page":"262","article-title":"Aggregation in Huntington\u2019s disease: insights through modelling.","volume":"16","author":"B Cajavec","year":"2005","journal-title":"Genome Inform"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/hmg\/ddi071","article-title":"A structure-based analysis of huntingtin mutant polyglutamine aggregation and toxicity: evidence for a compact beta-sheet structure.","volume":"14","author":"MA Poirier","year":"2005","journal-title":"Hum Mol Genet"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.1074\/jbc.M110.192013","article-title":"A compact beta model of huntingtin toxicity.","volume":"286","author":"QC Zhang","year":"2011","journal-title":"J Biol Chem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1523\/JNEUROSCI.16-17-05523.1996","article-title":"Expression of normal and mutant huntingtin in the developing brain.","volume":"16","author":"PG Bhide","year":"1996","journal-title":"J Neurosci"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1515\/REVNEURO.2010.21.4.273","article-title":"Antibody therapy in neurodegenerative disease.","volume":"21","author":"AL Southwell","year":"2010","journal-title":"Rev Neurosci"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"9989","DOI":"10.1073\/pnas.96.18.9989","article-title":"Amyloid diseases: Abnormal protein aggregation in neurodegeneration.","volume":"96","author":"EH Koo","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0076-6879(99)09019-9","article-title":"Analysis of protein aggregation kinetics.","volume":"309","author":"F Ferrone","year":"1999","journal-title":"Methods Enzymol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nchembio0606-297","article-title":"Nucleation of huntingtin aggregation in cells.","volume":"2","author":"R Wetzel","year":"2006","journal-title":"Nat Chem Biol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nchembio792","article-title":"Stochastic kinetics of intracellular huntingtin aggregate formation.","volume":"2","author":"DW Colby","year":"2006","journal-title":"Nat Chem Biol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1523\/JNEUROSCI.19-04-01189.1999","article-title":"Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington\u2019s disease.","volume":"19","author":"FR Fusco","year":"1999","journal-title":"J Neurosci"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0896-6273(95)90345-3","article-title":"Widespread expression of Huntington\u2019s disease gene (IT15) protein product.","volume":"14","author":"AH Sharp","year":"1995","journal-title":"Neuron"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.neuroscience.2007.03.036","article-title":"Dopamine-dependent long term potentiation in the dorsal striatum is reduced in the R6\/2 mouse model of Huntington\u2019s disease.","volume":"146","author":"VW Kung","year":"2007","journal-title":"Neuroscience"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1523\/JNEUROSCI.23-03-00961.2003","article-title":"Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington\u2019s disease.","volume":"23","author":"C Cepeda","year":"2003","journal-title":"J Neurosci"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"10371","DOI":"10.1523\/JNEUROSCI.1592-09.2009","article-title":"Alterations in cortical excitation and inhibition in genetic mouse models of Huntington\u2019s disease.","volume":"29","author":"DM Cummings","year":"2009","journal-title":"J Neurosci"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1523\/JNEUROSCI.3539-10.2011","article-title":"Differential electrophysiological changes in striatal output neurons in Huntington\u2019s disease.","volume":"31","author":"VM Andr\u00e9","year":"2011","journal-title":"J Neurosci"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1074\/jbc.M410210200","article-title":"Neuroprotective effects of phenylbutyrate in the N171\u201382Q transgenic mouse model of Huntington\u2019s disease.","volume":"280","author":"G Gardian","year":"2005","journal-title":"J Biol Chem"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease.","volume":"12","author":"EJ Slow","year":"2003","journal-title":"Hum Mol Genet"},{"key":"ref60","first-page":"6182","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci.","volume":"28","author":"M Gray","year":"2008"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.1523\/JNEUROSCI.22-18-08266.2002","article-title":"Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington\u2019s disease knock-in mice.","volume":"22","author":"LB Menalled","year":"2002","journal-title":"J Neurosci"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1523\/JNEUROSCI.20-01-00219.2000","article-title":"Intraneuronal aggregate formation and cell death after viral expression of expanded polyglutamine tracts in the adult rat brain.","volume":"20","author":"MC Senut","year":"2000","journal-title":"J Neurosci"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/hmg\/10.17.1829","article-title":"Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington\u2019s disease.","volume":"10","author":"A Wyttenbach","year":"2001","journal-title":"Hum Mol Genet"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/326194a0","article-title":"Homozygotes for Huntington\u2019s disease.","volume":"326","author":"NS Wexler","year":"1987","journal-title":"Nature"},{"key":"ref65","first-page":"615","article-title":"Homozygote for Huntington disease.","volume":"45","author":"RH Myers","year":"1989","journal-title":"Am J Hum Genet"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199405193302001","article-title":"A worldwide study of the Huntington\u2019s disease mutation.","volume":"330","author":"B Kremer","year":"1994","journal-title":"N Engl J Med"},{"key":"ref67","first-page":"172","article-title":"Homozygosity in Huntington\u2019s disease.","volume":"36","author":"A Durr","year":"1999","journal-title":"J Med Genet"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1212\/WNL.53.4.801","article-title":"DNA analysis of Huntington\u2019s disease. Five years of experience in Germany, Austria, and Switzerland.","volume":"53","author":"F Laccone","year":"1999","journal-title":"Neurology"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/brain\/awg077","article-title":"Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course.","volume":"126","author":"F Squitieri","year":"2003","journal-title":"Brain"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"19385","DOI":"10.1074\/jbc.271.32.19385","article-title":"Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme.","volume":"271","author":"MA Kalchman","year":"1996","journal-title":"J Biol Chem"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nature06022","article-title":"Global changes to the ubiquitin system in Huntington\u2019s disease.","volume":"448","author":"EJ Bennett","year":"2007","journal-title":"Nature"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/B:SCAM.0000007124.19463.e5","article-title":"Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins.","volume":"24","author":"CC Huang","year":"1998","journal-title":"Somat Cell Mol Genet"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.96.20.11404","article-title":"Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells.","volume":"96","author":"A Kazantsev","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.","volume":"413","author":"JS Steffan","year":"2001","journal-title":"Nature"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/hmg\/9.14.2197","article-title":"CREB-binding protein sequestration by expanded polyglutamine.","volume":"9","author":"A McCampbell","year":"2000","journal-title":"Hum Mol Genet"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","article-title":"Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity.","volume":"291","author":"FC Nucifora Jr","year":"2001","journal-title":"Science"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0041450","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T18:12:27Z","timestamp":1589047947000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0041450"}},"subtitle":[],"editor":[{"given":"Zhenyu","family":"Yue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,7,24]]},"references-count":76,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2012,7,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0041450","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,24]]}}}